Literature DB >> 11090867

The split hand in ALS has a cortical basis.

M Weber1, A Eisen, H Stewart, N Hirota.   

Abstract

Loss of highly fractionated movement involving the thumb and index finger is an early characteristic of hand dysfunction in many ALS patients. These movements are largely subserved by the 'thenar complex' including the first dorsal interosseus muscle (FDI), whereas the 'hypothenar complex', innervated by the same myotome, has less ability to fractionate and is relatively spared. This suggests that in ALS, hand dysfunction and wasting is related to corticomotoneuronal representation and input. To determine whether corticomotoneuronal input to the thenar spinal pool is preferentially impaired compared to the hypothenar spinal pool in ALS, we studied 18 ALS patients and 11 normal subjects. Compound muscle action potentials (CMAPs) and motor evoked potentials (MEPs) of the thenar and hypothenar complexes were evoked by peripheral nerve stimulation and transcranial magnetic stimulation. In healthy control subjects the cortical/peripheral (MEP/CMAP) ratios were significantly larger for the thenar complex suggesting a stronger corticomotoneuronal input to this muscle complex (P<0.005). This was not the case in ALS patients. Comparing the ratios between control subjects and patients revealed a significant reduction for the thenar complex (P<0.02) in ALS patients but not for the hypothenar complex. We conclude that corticomotoneuronal input to the thenar complex is preferentially affected in ALS and that corticomotoneuronal disease may be the prime determinant of hand dysfunction and wasting.

Entities:  

Mesh:

Year:  2000        PMID: 11090867     DOI: 10.1016/s0022-510x(00)00430-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

Review 1.  Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

Authors:  Kevin Talbot
Journal:  J Anat       Date:  2013-09-08       Impact factor: 2.610

2.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

Review 3.  Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.

Authors:  Dzung Do-Ha; Yossi Buskila; Lezanne Ooi
Journal:  Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.590

4.  Terminal latency abnormality in amyotrophic lateral sclerosis without split hand syndrome.

Authors:  Donghwi Park; Jin-Sung Park
Journal:  Neurol Sci       Date:  2017-02-10       Impact factor: 3.307

5.  Utility of dissociated intrinsic hand muscle atrophy in the diagnosis of amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Steve Vucic
Journal:  J Vis Exp       Date:  2014-03-04       Impact factor: 1.355

6.  CMAP decrement by low-frequency repetitive nerve stimulation in different hand muscles of ALS patients.

Authors:  Dong Zhang; Yuying Zhao; Chuanzhu Yan; Lili Cao; Wei Li
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

Review 7.  Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?

Authors:  Tadashi Kanouchi; Takuya Ohkubo; Takanori Yokota
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-04-27       Impact factor: 10.154

Review 8.  Motoneuron firing in amyotrophic lateral sclerosis (ALS).

Authors:  Mamede de Carvalho; Andrew Eisen; Charles Krieger; Michael Swash
Journal:  Front Hum Neurosci       Date:  2014-09-22       Impact factor: 3.169

Review 9.  The Cortical "Upper Motoneuron" in Health and Disease.

Authors:  Roger N Lemon
Journal:  Brain Sci       Date:  2021-05-12

10.  Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Matthew C Kiernan; Steve Vucic
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.